Avadel Pharmaceuticals (AVDL) Other Non-Current Assets (2016 - 2022)
Historic Other Non-Current Assets for Avadel Pharmaceuticals (AVDL) over the last 14 years, with Q3 2022 value amounting to $11.7 million.
- Avadel Pharmaceuticals' Other Non-Current Assets fell 6923.72% to $11.7 million in Q3 2022 from the same period last year, while for Sep 2022 it was $11.7 million, marking a year-over-year decrease of 6923.72%. This contributed to the annual value of $33.8 million for FY2021, which is 3543.85% up from last year.
- According to the latest figures from Q3 2022, Avadel Pharmaceuticals' Other Non-Current Assets is $11.7 million, which was down 6923.72% from $11.8 million recorded in Q2 2022.
- In the past 5 years, Avadel Pharmaceuticals' Other Non-Current Assets registered a high of $47.5 million during Q1 2020, and its lowest value of $11.7 million during Q3 2022.
- Over the past 5 years, Avadel Pharmaceuticals' median Other Non-Current Assets value was $33.8 million (recorded in 2021), while the average stood at $30.3 million.
- As far as peak fluctuations go, Avadel Pharmaceuticals' Other Non-Current Assets surged by 25267.83% in 2018, and later plummeted by 6923.72% in 2022.
- Quarter analysis of 5 years shows Avadel Pharmaceuticals' Other Non-Current Assets stood at $36.1 million in 2018, then rose by 8.65% to $39.3 million in 2019, then plummeted by 36.5% to $24.9 million in 2020, then surged by 35.44% to $33.8 million in 2021, then tumbled by 65.3% to $11.7 million in 2022.
- Its last three reported values are $11.7 million in Q3 2022, $11.8 million for Q2 2022, and $39.6 million during Q1 2022.